ホーム › 悪性黒色腫 › ウィスコンシン › Madison
Madison、WIにおける悪性黒色腫の臨床試験
Madisonとその周辺地域（約30マイル以内）の拠点で、悪性黒色腫に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
被験者募集中第1/2相
- UW Hospital and Clinics, Madison
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
被験者募集中第3相
- University of Wisconsin Carbone Cancer Center, Madison
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
被験者募集中第2相
- Local Institution - 0134, Madison
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
被験者募集中第2相
- University of Wisconsin Carbone Cancer Center, Madison
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
被験者募集中第1/2相
- University of Wisconsin-Madison Carbone Cancer Center, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
被験者募集中第1/2相
- The Board of Regents of the University of Wisconsin, Madison
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- University of Wisconsin- Madison, Madison
Neoadjuvant Darovasertib in Primary Uveal Melanoma
被験者募集中第3相
- University of Wisconsin Health, Madison
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
被験者募集中第2/3相
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
被験者募集中観察研究
- University of Wisconsin Hospitals and Clinics (UWHC), Madison
In Vivo Liquid Biopsy of Melanoma (Cytophone)
被験者募集中健康なボランティア歓迎
- SSM Health Dean Medical Group Specialty Services, Madison
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- University of Winsconsin Carbone Cancer Center-Eastpark medical Center, Madison
- University of Wisconsin Carbone Cancer Center, Madison
他の都市における悪性黒色腫の試験
- Houston, TX59件の研究
- New York City, NY38件の研究
- Los Angeles, CA34件の研究
- Nashville, TN33件の研究
- Pittsburgh, PA31件の研究
- Boston, MA26件の研究
- Philadelphia, PA23件の研究
- San Francisco, CA22件の研究
- Atlanta, GA21件の研究
- Durham, NC21件の研究
- St. Louis, MO21件の研究
- Columbus, OH21件の研究
Madisonにおける他の研究
- 前立腺がん29件の研究
- 大腸癌22件の研究
- 乳がん22件の研究
- 転移性癌21件の研究
- 非小細胞肺癌16件の研究
- 急性骨髄性白血病16件の研究
- がん（全種類）14件の研究
- 卵巣がん13件の研究
- 胃癌11件の研究
- 肺がん10件の研究
- 膵臓がん10件の研究
- 多発性骨髄腫9件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。